Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Theravance Biopharma R&D IP, LLC”

252 pharma patents match "Theravance Biopharma R&D IP, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 252
Index total 30,257
Page 9 / 11

Quick answer

This filtered view shows 252 pharmaceutical patents matching "Theravance Biopharma R&D IP, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

252 results for “Theravance Biopharma R&D IP, LLC” · 30,257 patents in full index Clear search

  1. US 9221763

    Process for preparing biphenyl imidazole compounds

    Theravance Biopharma R&D IP, LLC · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  2. US 9216971

    Quaternary ammonium compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted
  3. US 9216970

    Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

    Theravance Biopharma R&D IP, LLC · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted
  4. US 9212168

    Hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted
  5. US 9206159

    Piperazine-piperidine compounds as hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted
  6. US 9206172

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted
  7. US 9199993

    8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  8. US 9198899

    Dual-acting benzoimidazole antihypertensive agents

    Theravance Biopharma R&D IP, LLC · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  9. US 9187423

    Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  10. US 9181206

    Dual-acting oxazole antihypertensive agents

    Theravance Biopharma R&D IP, LLC · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted
  11. US 9162982

    4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  12. US 9150514

    Dual-acting antihypertensive agents

    Theravance Biopharma R&D IP, LLC · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  13. US 9150500

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  14. US 9126994

    Crystalline form of a quinolinone-carboxamide compound

    Theravance Biopharma R&D IP, LLC · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  15. US 9126956

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  16. US 9120758

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  17. US 9120746

    Crystalline form of a 3-phenoxymethylpyrrolidine compound

    Theravance Biopharma R&D IP, LLC · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  18. US 9120747

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  19. US 9108934

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  20. US 9096496

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted
  21. US 9073859

    Crystalline form of a 4-[2-(2-fluorophenoxymethyl) phenyl]piperidine compound

    Theravance Biopharma R&D IP, LLC · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted
  22. US 9066944

    Hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted
  23. US 9045443

    Nitric oxide donor neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  24. US 9035061

    Process for preparing a biphenyl-2-ylcarbamic acid

    Theravance Biopharma R&D IP, LLC · Granted May 19, 2015 · Expires May 14, 2035

    granted